About Index Trending news
Analyze
Pricing
NovImmune

NovImmune

Work at NovImmune? Add yourself to this profile

NovImmune

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Edit Profile
More info

Elsewhere

Also headquartered in Geneva

Seedstars World Seedstars World ProtonMail ProtonMail Silent Circle Silent Circle Index Ventures Index Ventures seedstars seedstars CERN CERN World Economic Forum World Economic Forum News News MB&F MB&F WISeKey WISeKey

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
17 Dec 2010
$22,413,980
Venture capital (Series D)
BZ Bank
12 May 2009
$54,800,000
Venture capital (Series C)
Novartis Venture Fund, Aravis Ventures, BZ Bank, +4
01 Jun 2006
$46,000,000
Venture capital (Series B)
Novartis Venture Fund, Aravis Ventures, BZ Bank, +2
01 May 2000
$14,000,000
Venture capital (Series A)
Novartis Venture Fund, LODH Immunology Fund